June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
Lucy’s Story: Immunotherapy Trial Gives Lymphoma Patient New Hope
July 19, 2018 | Dory Benford
After many complications, City of Hope lymphoma patient Lucy found renewed hope after an immunotherapy clinical trial.
Surprising Diagnosis Leads Skin Cancer Patient to City of Hope
May 29, 2018 | Robert Young
Barbara Dorfman ran a large nursery school for 25 years, helped raise five children and has enjoyed an exceptionally active lifestyle with her husband, but nothing could prepare her for the diagnosis she received four years ago.
Patient with Rare Skin Cancer Grateful for City of Hope Dermatology Team
May 22, 2018 | Robert Young
When what he thought was just a rash on his forehead spread to his face and neck, Joshua Singer sought medical help. After a number of treatments failed to figure out the problem, he turned to City of Hope, and renowned dermatologist Christiane Querfeld. M.D., Ph.D.
The Many Types of Skin Cancer: What You Should Know
May 21, 2018 | Kevin Chesley
Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope Christiane Querfeld, M.D., Ph.D.
City of Hope to offer CAR T cell therapy for patients with the most common type of NHL
May 4, 2018 | Letisia Marquez
City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.
Cheryl’s Story: CAR T Patient and Pioneer
April 30, 2018 | Letisia Marquez
Cheryl Wiers knew her cancer diagnosis happened for a reason, and for her, that reason could be her participation in a clinical trial using what is arguably the most promising cancer treatment — CAR T cell therapy.
City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors
March 14, 2018 | Katie Neith
In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.
‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma
March 6, 2018 | City of Hope
Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.